e.g. Filippa Pettersson or Cancer Res. 75(6) , 1102-12, (2015) or 10.1002/anie.201600521
Structure–activity relationship studies of ethyl 2-[(3-methyl-2, 5-dioxo (3-pyrrolinyl)) amino]-4-(trifluoromethyl) pyrimidine-5-carboxylate: an inhibitor of AP-1 and NF-κB …
Several analogues of ethyl 2-[(3-methyl-2, 5-dioxo (3-pyrrolinyl)) amino]-4-(trifluoromethyl) pyrimidine-5-carboxylate (1) were synthesized and tested as inhibitors of AP-1 and NF-κB mediated transcriptional activation in Jurkat T cells. From our SAR work, ethyl 2-[(3-methyl-2, 5-dioxo (3-pyrrolinyl))-N-methylamino]-4-(trifluoromethyl)-pyrimidine-5-carboxylate was identified as a novel and potent inhibitor.